Herein, we report a case of a patient previously treated for benign prostatic hyperplasia (BPH) and was diagnosed with GS 5+5 prostate cancer with low PSA levels, which rapidly progressed and was accompanied by malignant priapism, leading to death 11 months after diagnosis. Here, KLK3 is linked to benign prostatic hyperplasia.